Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York (Reuters) - Johnson & Johnson ...

For nearly a decade, Toni Matthews-El has published business topics ranging from cloud communication software to best steps for establishing your own LLC. In addition to Forbes Advisor, she's ...

Johnson & Johnson last fall suffered a major legal defeat in its defense of antipsychotic Risperdal, but that loss was short-lived. After a jury ordered J&J to pay a plaintiff a staggering $8 billion, ...

A Philadelphia jury has ordered medical company Johnson & Johnson to pay $8 billion in punitive damages in the case of a man who said he developed breasts after taking the company's anti-psychotic ...

Johnson & Johnson's legal battles over opioid drugs and talc products may have made big headlines lately, but Tuesday, it lost big in an entirely different fight. Jurors in Philadelphia awarded a ...

In a blow to Johnson & Johnson, the company was ordered last Friday to pay $70 million to a male Tennessee teenager who claimed its Risperdal antipsychotic pill caused him to grow enlarged breasts.

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

Records from the Philadelphia County Court of Common Pleas reveal more than 3,000 new Risperdal lawsuits were filed in the first three months of 2017, driving up the total number of filings in this ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...

Oct 30 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop ...